| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to insurance coverage for certain devices used in the |
|
|
treatment of diabetes. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Sections 1358.051(1) and (2), Insurance Code, |
|
|
are amended to read as follows: |
|
|
(1) "Diabetes equipment" means: |
|
|
(A) blood glucose monitors, including |
|
|
noninvasive glucose monitors and glucose monitors designed to be |
|
|
used by blind individuals; |
|
|
(B) insulin pumps and associated appurtenances; |
|
|
(C) insulin infusion devices; |
|
|
(D) devices that facilitate insulin therapy and |
|
|
enhance glucose control; and |
|
|
(E) [(D)] podiatric appliances for the |
|
|
prevention of complications associated with diabetes. |
|
|
(2) "Diabetes supplies" means: |
|
|
(A) test strips for blood glucose monitors; |
|
|
(B) visual reading and urine test strips; |
|
|
(C) lancets and lancet devices; |
|
|
(D) insulin and insulin analogs; |
|
|
(E) injection aids; |
|
|
(F) syringes; |
|
|
(G) prescriptive and nonprescriptive oral agents |
|
|
for controlling blood sugar levels; [and] |
|
|
(H) glucagon emergency kits; |
|
|
(I) insulin pens; |
|
|
(J) insulin pen needles; |
|
|
(K) cartridges for pen injectors; |
|
|
(L) disposable prefilled insulin pens; |
|
|
(M) insulin delivery devices; and |
|
|
(N) devices that facilitate insulin therapy and |
|
|
enhance glucose control. |
|
|
SECTION 2. This Act applies only to an insurance policy that |
|
|
is delivered, issued for delivery, or renewed on or after January 1, |
|
|
2012. A policy delivered, issued for delivery, or renewed before |
|
|
January 1, 2012, is governed by the law as it existed immediately |
|
|
before the effective date of this Act, and that law is continued in |
|
|
effect for that purpose. |
|
|
SECTION 3. This Act takes effect September 1, 2011. |